Proxy Votes Now

Home › Activist investors › Value Base Ltd.

Value Base Ltd.

Campaign activist. Positions and campaigns from Value Base Ltd.’s SEC filings. Updated November 20, 2026.

Filer entities
Value Base Ltd.
SEC CIK
1992355 (Value Base Ltd.)
SEC filings
Schedule 13D filings · 13F reports · soliciting material
Latest 13F
Quarter ended Sep 30, 2026, filed Nov 10, 2026: 6 US-listed positions reported; 1 of 1% or more of a company without a 13D are listed below.
5current positions
0new or changed in 90 days
1active campaigns
1campaigns on record

Active campaigns (1)

RadCom Ltd

Active campaign Public letter or presentation filed · Mar 26, 2026

First 13DFeb 17, 2026
Latest filingMar 26, 2026
Filings (2)

Current positions (5)

CompanyStakeSourceFirst disclosedLast changeSince previous filingFlagsStated intent
RadCom Ltd 5.3%865,009 shares Schedule 13D/A, filed Mar 26, 2026 Feb 17, 2026 — 0.00 pts Active campaign Seeks changes or engagement
Valens Semiconductor Ltd. 20.8%21,299,896 shares Schedule 13D/A, filed Nov 24, 2025 Jul 23, 2024 Increased Nov 24, 2025 ▲ 1.36 pts — Standard Item 4 language
Teads Holding Co. 5.87%5,752,107 shares 13F, quarter ended Sep 30, 2026filed Nov 10, 2026; % of shares outstanding as of Jul 31, 2026 Feb 11, 2025 — 0.00 pts — 13F: none stated
Perion Network Ltd 5.6%2,528,710 shares Schedule 13D/A, filed Jul 14, 2025 Apr 21, 2025 Decreased Jul 14, 2025 ▼ 0.16 pts — Standard Item 4 language
Cognyte Software Ltd. — Schedule 13D/A, filed Sep 16, 2024stake not read from this filing’s format: see the filing Jun 26, 2024 — — — Standard Item 4 language

Stake: the latest 13D’s percent of the class (the largest single reporting person’s, as filed), or for a 13F the reported shares as a percent of the company’s shares outstanding on the date shown. Since previous filing: the change in percentage points against the investor’s previous 13D on the company, or its previous 13F.

Stated intent (13D Item 4)

Item 4 of a Schedule 13D (“Purpose of Transaction”) is where the investor states its plans. The label is a plain reading of that text; the excerpt is quoted from the filing.

RadCom Ltd · Seeks changes or engagement

“…directors appointed by the Board of Directors to fill vacancies prior to the Special Meeting shall terminate upon the conclusion of the Special Meeting, (iv) remove the following directors from the Company's Board of Directors, effective as of the conclusion of the Special Meeting: Rami Schwartz, Rachel (Hili) Bennun, Oren Most, Yaron Ravkeie and Andre Feutch, (v) nominate for election by shareholders of the following candidates for the Board of Directors…”

Item 4 in the Schedule 13D/A filed Mar 26, 2026.

Valens Semiconductor Ltd. · Standard Item 4 language

“Item 4 of the Schedule 13D is amended to add the following: In consideration for Mr. Yaacobi's services as a director, the Issuer made certain equity grants to Mr. Yaacobi on March 12, 2025 through a company wholly-owned by Mr. Yaacobi. These equity grants were as follows: (1) A total of 35,689 options to purchase Ordinary Shares of the Issuer (the "Options"), granted pursuant to the Issuer's 2021”

Item 4 in the Schedule 13D/A filed Nov 24, 2025.

Perion Network Ltd · Standard Item 4 language

“Item 4 of the Schedule 13D is amended to add the following: On July 14, 2025, VBF LP, through its external legal counsel, sent a letter to the Chairman of the Board of Directors of the Company (the "Additional Letter") welcoming the Company's decision to remove the previously adopted rights plan and highlighting, for the last time, several additional concerns that VBF LP believes the Board of Directors…”

Item 4 in the Schedule 13D/A filed Jul 14, 2025.

Cognyte Software Ltd. · Standard Item 4 language

“Item 4 of the Schedule 13D is amended to add the following: On August 27, 2024, the Reporting Persons issued a presentation titled “Value Base Group’s 2024 Value Creation Plan for Cognyte Software Ltd.” (the “ Presentation ”). A copy of the Presentation is filed herewith as Exhibit 6 and incorporated herein by reference. The description of the presentation contained in this Amendment No. 4 is qualified…”

Item 4 in the Schedule 13D/A filed Sep 16, 2024; this amendment did not restate Item 4, so the text is from the filing of Aug 27, 2024.

Past positions (1)
CompanyLast stakeSourceOutcomeDate
SHL Telemedicine LTD 15.2% Schedule 13D/A, filed Dec 5, 2025 Not in the 13F for the quarter ended Dec 31, 2025 Feb 9, 2026

How large managers voted in Value Base Ltd.’s proxy contests (meetings since July 2023)

Fund votes come from Form N-PX filings, which this site holds from July 1, 2023 (meetings through June 30, 2026; later meetings appear when the managers file their next N-PX); earlier contests and campaigns that settled before a vote are listed under the activist’s campaigns.

No proxy contest has gone to a vote since July 1, 2023.

Track record

How each campaign on record ended, as read from the filings: settlements disclosed in the company’s 8-K or the investor’s 13D, contested votes (8-K Item 5.07), withdrawals and 13D amendments below 5%.

1Ongoing
Outcome of each campaign (1)
CompanyOutcomeDetailDateFirst filing
RadCom Ltd Ongoing Public letter or presentation filed Mar 26, 2026 Feb 17, 2026

Share price after the first 13D

The change in the company’s closing share price from the first trading day on or before the investor’s first Schedule 13D to the latest close, and to 6 and 12 months after it, beside the S&P 500 (SPY) over the same dates. This is a price change after a filing date: it is not attributed to the investor, and it is not the investor’s return. Coverage: 1 of 5 13D positions have prices (the site’s daily price history starts November 10, 2025, and covers only listed tickers it tracks).

CompanyFirst 13DTo latest closeSPY same dates6 months after12 months after
RadCom Ltd RDCM Feb 17, 2026 -7.3%Feb 17, 2026 – Nov 18, 2026 +6.9% -15.6%SPY +12.6% not yet / no price

Prices: daily closes (Nasdaq), as stored by the site.

Other disclosed holders around the same time

Filings by other activists on this list (their first 13D or 13F on the company) and by other holders of 5% or more (Schedule 13D or 13G) dated within 180 days of Value Base Ltd.’s first disclosure in the same company. They are listed together by date only; nothing here says the holders act together.

RadCom Ltd · Value Base Ltd. first disclosed Feb 17, 2026 · 1 other filing
HolderFormDateStake
Lynrock Lake LP Schedule 13D Feb 24, 2026 19.3%
Perion Network Ltd · Value Base Ltd. first disclosed Apr 21, 2025 · 1 other filing
HolderFormDateStake
Phoenix Financial Ltd. Schedule 13D Jun 30, 2025 5.7%
Teads Holding Co. · Value Base Ltd. first disclosed Feb 11, 2025 · 1 other filing
HolderFormDateStake
Patrick Drahi Schedule 13D Feb 10, 2025 46.8%
SHL Telemedicine LTD · Value Base Ltd. first disclosed Dec 21, 2023 · 1 other filing
HolderFormDateStake
Danbar Finance Ltd. Schedule 13D Dec 26, 2023 4.9%

How to read this

Flags (last 90 days)
New first disclosed in the last 90 days. Increased / Decreased shares up or down in a 13D/A or 13F filed in that time. Below 5% a 13D/A reported less than 5%, the reporting threshold. Exited a 13D/A reported no shares, or the investor’s 13F no longer lists a company it listed before.
Active campaign
A contested meeting at which the investor is soliciting proxies is still to be held; or in the last 12 months it filed a proxy-contest document (PREC14A, DEFC14A or DFAN14A soliciting material), stated in a 13D that it nominated directors, filed a letter or presentation to the board or shareholders, or stated public demands in a 13D — and no settlement, withdrawal, contested vote or 13D below 5% is dated on or after the latest such filing. Status is the furthest step since then: Public demands in a 13D < Public letter or soliciting material < Nominations made < Proxy contest filed.
Sources and limits
SEC EDGAR only. 13D data covers filings since June 2023; 13F reports are quarterly and filed up to 45 days after the quarter, and do not show swaps, most options or non-US holdings. Settlements are cooperation agreements disclosed in the company’s 8-K or stated in the investor’s 13D; board seats are read from the 8-K. Text marked Summary of the filing is checked against the filing, whose words are quoted beside it. Nothing on this page predicts what the investor will do.